Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 731208, 6 pages
http://dx.doi.org/10.1155/2012/731208
Research Article

Epimedium koreanum Extract and Its Constituent Icariin Improve Motor Dysfunction in Spinal Cord Injury

Division of Neuromedical Science, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan

Received 8 May 2012; Accepted 11 July 2012

Academic Editor: Jairo Kenupp Bastos

Copyright © 2012 Chihiro Tohda and Aiko Nagata. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. G. Fehlings and D. C. Baptiste, “Current status of clinical trials for acute spinal cord injury,” Injury, vol. 36, no. 2, pp. SB113–SB122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Kronvall, F. T. Sayer, and O. G. Nilsson, “More and more questions about the use of methylprednisolone for the treatment of acute spinal cord injury,” Lakartidningen, vol. 102, no. 24-25, pp. 1887–1890, 2005. View at Google Scholar · View at Scopus
  3. L. C. Weaver, D. Gris, L. R. Saville et al., “Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment,” Journal of Neurotrauma, vol. 22, no. 12, pp. 1375–1387, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Okada, M. Nakamura, H. Katoh et al., “Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury,” Nature Medicine, vol. 12, no. 7, pp. 829–834, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. D. Pearse, F. C. Pereira, A. E. Marcillo et al., “cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury,” Nature Medicine, vol. 10, no. 6, pp. 610–616, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Kuboyama, C. Tohda, and K. Komatsu, “Neuritic regeneration and synaptic reconstruction induced by withanolide A,” British Journal of Pharmacology, vol. 144, no. 7, pp. 961–971, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Kuboyama, C. Tohda, and K. Komatsu, “Withanoside IV and its active metabolite, sominone, attenuate Aβ(25–35)-induced neurodegeneration,” European Journal of Neuroscience, vol. 23, no. 6, pp. 1417–1426, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Tohda, N. Matsumoto, K. Zou, M. R. Meselhy, and K. Komatsu, “Aβ(25–35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by MI, a metabolite of protopanaxadiol-type saponins,” Neuropsychopharmacology, vol. 29, no. 5, pp. 860–868, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Tohda and E. Joyashiki, “Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET,” British Journal of Pharmacology, vol. 157, no. 8, pp. 1427–1440, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Nakayama and C. Tohda, “Withanoside IV improves hindlimb function by facilitating axonal growth and increase in peripheral nervous system myelin level after spinal cord injury,” Neuroscience Research, vol. 58, no. 2, pp. 176–182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. N. R. Krenz and L. C. Weaver, “Nerve growth factor in glia and inflammatory cells of the injured rat spinal cord,” Journal of Neurochemistry, vol. 74, no. 2, pp. 730–739, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. H. K. Kang, Y.-H. Choi, H. Kwon et al., “Estrogenic/antiestrogenic activities of a Epimedium koreanum extract and its major components: in vitro and in vivo studies,” Food and Chemical Toxicology, vol. 50, no. 8, pp. 2751–2759.
  13. D. M. Basso, L. C. Fisher, A. J. Anderson, L. B. Jakeman, D. M. McTigue, and P. G. Popovich, “Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains,” Journal of Neurotrauma, vol. 23, no. 5, pp. 635–659, 2006. View at Google Scholar · View at Scopus
  14. C. L. Li, L. Zhang, H. T. Gu et al., “The in vivo anti-tumor effects of Icariin and its mechanisms,” Chinese Journal of Cancer Biotherapy, vol. 14, pp. 137–142, 2007. View at Google Scholar
  15. L. Li, Q. Wu, Q. X. Zhou, and J. S. Shi, “Protective effect of icariin against mitochondrial damage induced by oxygen free radical in rat cerebral cells,” Chinese Journal of Pharmacology and Toxicology, vol. 19, no. 5, pp. 333–337, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. W. Pan, Q. J. Wang, J. Xu, B. S. Du, and L. Y. Kong, “Effects of icariin on the isolated hearts and hemorheology of rats,” Journal of China Pharmaceutical University, vol. 38, no. 5, pp. 429–432, 2007. View at Google Scholar · View at Scopus
  17. Y. Pan, L. D. Kong, X. Xia, W. Y. Zhang, Z. H. Xia, and F. X. Jiang, “Antidepressant-like effect of icariin and its possible mechanism in mice,” Pharmacology Biochemistry and Behavior, vol. 82, no. 4, pp. 686–694, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Q. Xu, B. J. Liu, J. F. Wu et al., “Icariin attenuates LPS-induced acute inflammatory responses: involvement of PI3K/Akt and NFκB signaling pathway,” European Journal of Pharmacology, vol. 642, no. 1–3, pp. 146–153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Urano and C. Tohda, “Icariin improves memory impairment in Alzheimer's disease model mice (5xFAD) and attenuates amyloid β-induced neurite atrophy,” Phytotherapy Research, vol. 24, no. 11, pp. 1658–1663, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. C. A. Oyinbo, “Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade,” Acta Neurobiologiae Experimentalis, vol. 71, no. 2, pp. 281–299, 2011. View at Google Scholar · View at Scopus
  21. X. L. He, W. Q. Zhou, M. G. Bi, and G. H. Du, “Neuroprotective effects of icariin on memory impairment and neurochemical deficits in senescence-accelerated mouse prone 8 (SAMP8) mice,” Brain Research, vol. 1334, pp. 73–83, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Wang, L. Zhang, Z. B. Chen, J. Y. Wu, X. Zhang, and Y. Xu, “Icariin enhances neuronal survival after oxygen and glucose deprivation by increasing SIRT1,” European Journal of Pharmacology, vol. 609, no. 1–3, pp. 40–44, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. W. W. Li, X. M. Gao, X. M. Wang, H. Guo, and B. L. Zhang, “Icariin inhibits hydrogen peroxide-induced toxicity through inhibition of phosphorylation of JNK/p38 MAPK and p53 activity,” Mutation Research, vol. 708, no. 1-2, pp. 1–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Liu, H. Zhang, C. Xu et al., “Neuroprotective effects of icariin on corticosterone-induced apoptosis in primary cultured rat hippocampal neurons,” Brain Research, vol. 1375, pp. 59–67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Horiuchi, T. Ogata, T. Morino, M. Chuai, and H. Yamamoto, “Continuous intrathecal infusion of SB203580, a selective inhibitor of p38 mitogen-activated protein kinase, reduces the damage of hind-limb function after thoracic spinal cord injury in rat,” Neuroscience Research, vol. 47, no. 2, pp. 209–217, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Xu, B. R. Wang, X. Wang et al., “ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury,” Life Sciences, vol. 79, no. 20, pp. 1895–1905, 2006. View at Publisher · View at Google Scholar · View at Scopus